Last Updated on
March 24, 2025
By
Excedr
Leasing lab equipment isn’t just a financial decision—it’s a strategic advantage. For biotech startups and life science companies, staying ahead in your research requires access to the latest technology. But purchasing equipment outright ties up capital, limits flexibility, and risks obsolescence. Leasing offers a smarter alternative.
By spreading costs over time, leasing preserves cash flow for critical investments like R&D, hiring, and scaling. Instead of committing large sums to depreciating assets, businesses can allocate resources where they drive the most impact—fueling growth and accelerating discoveries.
In fast-evolving fields, where technology can become outdated in just a few years, leasing ensures labs stay equipped with the latest advancements without the financial burden of ownership. Even when long-term ROI considerations favor purchasing, leasing still provides advantages like lower upfront costs, reduced maintenance responsibilities, and greater adaptability.
The key to maximizing ROI isn’t just choosing between leasing and buying—it’s structuring financial decisions to align with business needs and industry trends. In this article, we’ll break down how to calculate ROI, explore the financial and strategic benefits of leasing, and help you determine when leasing is the best move for your lab.
Return on investment (ROI) helps determine whether leasing or purchasing lab equipment makes the most financial sense. It measures the financial impact by comparing the benefits gained from the equipment against the total cost over its useful life.
To calculate ROI for leasing, use this formula:
ROI = (Total Benefit minus Total Cost) divided by Total Cost, then multiplied by 100
For a deeper financial assessment, businesses often use net present value (NPV) and internal rate of return (IRR):
Consider a high-performance liquid chromatography (HPLC) system, a common piece of lab equipment in life sciences and healthcare:
IMAGE
Leasing may cost more over time ($120,000 vs. a net $80,000 after resale), but it preserves cash flow, reduces upfront costs, and allows for equipment upgrades. If the HPLC becomes obsolete within five years, leasing eliminates the risk of owning outdated technology.
Biotech startups and CFOs often use Excel models or ROI calculators to analyze leasing decisions. These tools factor in interest rates, depreciation, lease payments, and operating costs to determine break-even points and long-term financial impact. Running an NPV or IRR analysis provides a more strategic view of whether leasing aligns with your financial goals.
By evaluating these metrics, biotech companies can make informed leasing decisions that maximize ROI while balancing capital efficiency and innovation.
Leasing lab equipment helps biotech companies preserve cash flow, reduce upfront costs, and manage budgets more effectively. Instead of making a large purchase, leasing spreads the cost over time, keeping monthly payments predictable and leaving more cash available for critical expenses like R&D and hiring.
For example, instead of paying $500,000 upfront for a mass spectrometer, a company could lease it for $12,000 per month, keeping capital free for growth. This is especially valuable for startups and life sciences firms that need flexibility to scale.
Leasing can also provide tax advantages, as monthly lease payments are often deductible, whereas buying requires spreading deductions over time through depreciation. Additionally, leasing helps companies avoid owning outdated technology, as they can upgrade to newer equipment at the end of the lease instead of dealing with resale or obsolescence.
On the balance sheet, leasing can improve financial ratios by keeping more cash on hand and avoiding large capital expenditures. Instead of tying up money in expensive lab equipment, businesses can focus on expanding operations and securing partnerships.
Leasing also affects financial ratios. For example, a biotech startup with $500,000 in cash and $1 million in short-term liabilities has a current ratio of 0.5 (a lower number, signaling risk). By leasing instead of purchasing, they keep more cash on hand, which improves liquidity and financial health, making them more attractive to investors.
For a startup developing a new diagnostic assay, leasing an automated liquid handling system for $7,500 per month instead of spending $300,000 upfront allows them to start immediately without draining resources. This makes leasing a smart choice for companies that need financial flexibility and access to cutting-edge technology.
If you’re interested in learning more about the ways in which leasing may impact your lab’s financials (positively or negatively), running an ROI calculator or financial model in Excel can help. You’ll want to compare monthly lease payments, total cost, and cash flow impact to make an informed decision.
You might also be curious about how leasing affects your company’s financial health? Looking at key metrics like net present value (NPV), internal rate of return (IRR), and debt-to-equity ratio can provide deeper insights into the long-term ROI of leasing vs. buying.
Ultimately, these next steps will help you decide if leasing is the right choice or not. Evaluating your budgeting needs, growth plans, and equipment lifecycle can help determine whether leasing or purchasing provides the best return on investment. Beyond the numbers, leasing also reduces downtime, simplifies budgeting, and helps companies stay agile. Next, we’ll look at the strategic advantages beyond just cost savings.
Leasing lab equipment isn’t just about cost savings—it also provides strategic advantages that can impact productivity, flexibility, and long-term success. While financial benefits like cash flow management and budgeting stability are crucial, leasing also enables operational agility, access to cutting-edge technology, and reduced downtime, making it a valuable tool for biotech startups and established labs alike.
Science moves fast, and lab equipment can become outdated in just a few years. Purchasing means committing to a long-term investment in equipment that may lose value or become obsolete. Leasing, however, ensures that companies always have access to the latest advancements in automation, diagnostics, and research tools without worrying about resale or depreciation.
For example, a life sciences company working in genomics or molecular biology may need an NGS sequencer to stay ahead of industry standards. Leasing allows them to upgrade to a next-gen model every few years, ensuring they’re always using the most efficient and powerful technology.
Leasing provides the flexibility to scale operations without long-term commitments. If research priorities shift or funding changes, companies can adjust their equipment needs without being locked into ownership. This is particularly useful for startups that may need to pivot quickly or labs that experience fluctuations in demand.
Equipment failures can disrupt research and delay critical milestones. When purchasing, labs must handle repairs, maintenance, and replacement costs themselves. Leasing shifts much of this responsibility to the provider, ensuring minimal disruptions and guaranteed support for troubleshooting and replacements.
For example, a biotech startup leasing a flow cytometer can reduce the risk of downtime by working with a provider that offers ongoing maintenance and service agreements, ensuring uninterrupted workflow and compliance with research timelines.
For startups seeking venture capital funding or research partnerships, maintaining a strong balance sheet and demonstrating financial flexibility can make them more attractive to investors and collaborators. Leasing keeps capital free for expanding teams, entering new markets, or securing grants, all of which help build a stronger long-term growth strategy.
Leasing also makes it easier to align equipment needs with strategic goals. Instead of being tied to outdated technology or high initial investments, labs can continuously optimize their workflow and operations.
While leasing helps optimize total cost and return on investment, its biggest advantage is enabling biotech companies to stay agile, scale effectively, and access cutting-edge equipment without financial strain. Next, we’ll explore when leasing makes the most sense and how to maximize ROI for long-term success.
Leasing lab equipment isn’t always the best option, but in many cases, it provides a higher return on investment by reducing upfront costs, preserving cash flow, and offering flexibility. Understanding when leasing is the better choice—and how to structure lease agreements effectively—ensures businesses get the most value from their investment.
Leasing is most beneficial when:
For example, a biotech startup focused on CRISPR research may lease an automated cell imaging system instead of purchasing, knowing that in three years, advancements in imaging technology will likely make today’s model obsolete. Leasing gives them the ability to upgrade without a sunk-cost investment.
To get the most value from a lease agreement:
By structuring leases strategically, biotech companies can increase financial efficiency, improve budgeting, and maintain access to the best technology without long-term risk.
Leasing isn’t a one-size-fits-all solution, but when used strategically, it maximizes financial flexibility, minimizes risk, and ensures access to the best equipment. Next, we’ll summarize key takeaways and how companies can apply these insights to make the most informed decision for their lab.
Leasing lab equipment offers financial flexibility, access to cutting-edge technology, and lower upfront costs, making it a smart choice for many biotech startups and life sciences companies. By preserving cash flow, avoiding obsolescence, and ensuring predictable budgeting, leasing allows businesses to scale efficiently without tying up capital in depreciating assets.
When deciding whether to lease or buy, companies should consider:
For many biotech companies, leasing provides a strategic advantage by aligning financial resources with growth, innovation, and operational needs. Running an ROI calculator or conducting an NPV analysis can help businesses make an informed decision that supports long-term success.
Leasing is not just about cost savings—it’s about positioning your company for growth, agility, and financial efficiency in an industry that depends on cutting-edge technology and rapid advancements. Interested in equipment leasing? Get in touch with us today to begin your application and receive a lease estimate.
